Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Registry and Natural History Study for Progressive Myoclonus Epilepsy Type 1 (EPM1)

NCT06593951 is registered in ClinicalTrials.gov with Boston Children's Hospital as lead sponsor.

NCT NCT06593951
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06593951 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Registry and Natural History Study for Progressive Myoclonus Epilepsy Type 1 (EPM1)
Lead sponsor
Boston Children's Hospital
Phase
Observational
Overall status
Recruiting
Start date
October 10, 2024
Completion date
October 1, 2030
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cstb-related disease, epm1, myoclonus epilepsies, progressive, pme, progressive epilepsy and/or ataxia with myoclonus as a major feature, progressive myoclonus epilepsy type 1, progressive myoclonus-epilepsies, unverricht-lundborg disease